345 related articles for article (PubMed ID: 24644106)
1. Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial.
Alaka KJ; Noble W; Montejo A; Dueñas H; Munshi A; Strawn JR; Lenox-Smith A; Ahl J; Bidzan L; Dorn B; Ball S
Int J Geriatr Psychiatry; 2014 Sep; 29(9):978-86. PubMed ID: 24644106
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
Carter NJ; McCormack PL
CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
Rynn M; Russell J; Erickson J; Detke MJ; Ball S; Dinkel J; Rickels K; Raskin J
Depress Anxiety; 2008; 25(3):182-9. PubMed ID: 17311303
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine versus placebo in the treatment of patients with generalized anxiety disorder in China.
Wu WY; Wang G; Ball SG; Desaiah D; Ang QQ
Chin Med J (Engl); 2011 Oct; 124(20):3260-8. PubMed ID: 22088518
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial.
Hartford J; Kornstein S; Liebowitz M; Pigott T; Russell J; Detke M; Walker D; Ball S; Dunayevich E; Dinkel J; Erickson J
Int Clin Psychopharmacol; 2007 May; 22(3):167-74. PubMed ID: 17414743
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
Goldstein DJ; Mallinckrodt C; Lu Y; Demitrack MA
J Clin Psychiatry; 2002 Mar; 63(3):225-31. PubMed ID: 11926722
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.
Strawn JR; Prakash A; Zhang Q; Pangallo BA; Stroud CE; Cai N; Findling RL
J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):283-93. PubMed ID: 25791145
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies.
Davidson J; Allgulander C; Pollack MH; Hartford J; Erickson JS; Russell JM; Perahia D; Wohlreich MM; Carlson J; Raskin J
Hum Psychopharmacol; 2008 Aug; 23(6):519-26. PubMed ID: 18478624
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
Russell JM; Weisberg R; Fava M; Hartford JT; Erickson JS; D'Souza DN
Depress Anxiety; 2008; 25(7):E1-11. PubMed ID: 17587217
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder.
Boulenger JP; Loft H; Olsen CK
Int Clin Psychopharmacol; 2014 May; 29(3):138-49. PubMed ID: 24257717
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
Detke MJ; Lu Y; Goldstein DJ; Hayes JR; Demitrack MA
J Clin Psychiatry; 2002 Apr; 63(4):308-15. PubMed ID: 12000204
[TBL] [Abstract][Full Text] [Related]
12. A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.
Allgulander C; Nutt D; Detke M; Erickson J; Spann M; Walker D; Ball S; Russell J
J Psychopharmacol; 2008 Jun; 22(4):417-25. PubMed ID: 18635722
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
Allgulander C; Hartford J; Russell J; Ball S; Erickson J; Raskin J; Rynn M
Curr Med Res Opin; 2007 Jun; 23(6):1245-52. PubMed ID: 17559726
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.
Mallinckrodt CH; Prakash A; Andorn AC; Watkin JG; Wohlreich MM
J Psychiatr Res; 2006 Jun; 40(4):337-48. PubMed ID: 16271726
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
[TBL] [Abstract][Full Text] [Related]
18. Duloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studies.
Endicott J; Russell JM; Raskin J; Detke MJ; Erickson J; Ball SG; Marciniak M; Swindle RW
J Clin Psychiatry; 2007 Apr; 68(4):518-24. PubMed ID: 17474806
[TBL] [Abstract][Full Text] [Related]
19. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
Pollack MH; Zaninelli R; Goddard A; McCafferty JP; Bellew KM; Burnham DB; Iyengar MK
J Clin Psychiatry; 2001 May; 62(5):350-7. PubMed ID: 11411817
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Perahia DG; Wang F; Mallinckrodt CH; Walker DJ; Detke MJ
Eur Psychiatry; 2006 Sep; 21(6):367-78. PubMed ID: 16697153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
